drugset
drugset / Trial / NCT01648270

Buprenorphine Disposition and Cyclosporine

NCT01648270 ↗

Completed 25 enrolled Washington University School of Medicine
SequentialOpen-labelOther

Summary

The determine the effect of cyclosporine on buprenorphine disposition

Timeline

Start
2012-04
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 0.2 mg Intravenous
Subject Buprenorphine Other / unclassified 2 mg Intravenous

Indications

No indication recorded.